EFFECT OF 13-cis-RETINOIC ACID ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME
- 1 April 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 329 (8536) , 763-765
- https://doi.org/10.1016/s0140-6736(87)92796-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Human preleukaemia: do we have a model?British Journal of Cancer, 1987
- Prognostic Importance of Hypodiploid Hemopoietic Precursors in Myelodysplastic SyndromesNew England Journal of Medicine, 1986
- The myelodysplastic syndromesScandinavian Journal of Haematology, 1986
- Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes.Journal of Clinical Pathology, 1985
- Synergistic interaction between differentiation inducers and DNA synthesis inhibitors: A new approach to differentiation induction in myelodysplasia and acute myeloid leukaemiaLeukemia Research, 1985
- Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemiaBritish Journal of Haematology, 1984
- Response of Preleukemic Syndromes to Continuous Infusion of Low-Dose CytarabineNew England Journal of Medicine, 1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Ornithine Decarboxylase: Essential in Proliferation But Not Differentiation of Human Promyelocytic Leukemia CellsScience, 1982
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977